AAAAAA

   
Results: 1-9 |
Results: 9
Assessment of the efficacy and safety of Viagra (R) (sildenafil citrate) in men with erectile dysfunction during long-term treatment
Authors: Steers, W Guay, AT Leriche, A Gingell, C Hargreave, TB Wright, PJ Price, DE Feldman, RA
Citation: W. Steers et al., Assessment of the efficacy and safety of Viagra (R) (sildenafil citrate) in men with erectile dysfunction during long-term treatment, INT J IMPOT, 13(5), 2001, pp. 261-267
Denervation techniques have limited applicability - Questions and answers after H. Madersbacher and P. van Kerrebroeck (Reprinted from BJU Int, vol 85, pg 8-9, 2000)
Authors: Sauerwein, D Madersbacher, H Batista, J Brading, A Van Kerrebroeck, P Vale, P Susset, J Millard, R Steers, W
Citation: D. Sauerwein et al., Denervation techniques have limited applicability - Questions and answers after H. Madersbacher and P. van Kerrebroeck (Reprinted from BJU Int, vol 85, pg 8-9, 2000), UROLOGY, 55(5A), 2000, pp. A8-A9
Discussion - Pathogenesis of the overactive bladder and its attendant riskfactors (Reprinted from BJU Int, vol 85, pg 69, 2000)
Authors: Steers, W
Citation: W. Steers, Discussion - Pathogenesis of the overactive bladder and its attendant riskfactors (Reprinted from BJU Int, vol 85, pg 69, 2000), UROLOGY, 55(5A), 2000, pp. A69-A69
Pathogenesis of overactive bladder and its attendant risk factors - Questions and answers after P. Abrams and W. Steers (Reprinted from BJU Int, vol 85, pg 70-71, 2000)
Authors: Chacko, S Steers, W Hussain, I Daneshgari, F Abrams, P
Citation: S. Chacko et al., Pathogenesis of overactive bladder and its attendant risk factors - Questions and answers after P. Abrams and W. Steers (Reprinted from BJU Int, vol 85, pg 70-71, 2000), UROLOGY, 55(5A), 2000, pp. A70-A71
Sildenafil citrate (VIAGRA (R)) in the treatment of erectile dysfunction: analysis of two flexible dose-escalation studies
Authors: Feldman, R Meuleman, EJH Steers, W
Citation: R. Feldman et al., Sildenafil citrate (VIAGRA (R)) in the treatment of erectile dysfunction: analysis of two flexible dose-escalation studies, INT J CL PR, 1999, pp. 10-12
Open discussion following Dr. Trachtenberg's presentation
Authors: Goldenberg, L",Trachtenberg,"Steers, W Garnick, M Fair, W
Citation: W. Goldenberg, L",trachtenberg,"steers et al., Open discussion following Dr. Trachtenberg's presentation, MOL UROL, 3(3), 1999, pp. 251-251
Open discussion following Dr. Howell's presentation
Authors: Fair, W Howell, S Steers, W Heston, W Garnick, M Gleave, M Fourcroy, J
Citation: W. Fair et al., Open discussion following Dr. Howell's presentation, MOL UROL, 3(3), 1999, pp. 301-302
Open discussion following Dr. Feleppa's presentation
Authors: Steers, W",Feleppa,"Trachtenberg, J Frangioni, J Heston, W Fair, W
Citation: J. Steers, W",feleppa,"trachtenberg et al., Open discussion following Dr. Feleppa's presentation, MOL UROL, 3(3), 1999, pp. 311-311
Open discussion following Dr. Heston's presentation
Authors: Sufrin, G Heston, W Frangioni, J Garnick, M Howell, S Gleave, M Steers, W
Citation: G. Sufrin et al., Open discussion following Dr. Heston's presentation, MOL UROL, 3(3), 1999, pp. 321-321
Risultati: 1-9 |